Your browser doesn't support javascript.
loading
Impact of the treatment crossover design on comparative efficacy in EMPOWER-Lung 1: Cemiplimab monotherapy as first-line treatment of advanced non-small cell lung cancer.
Feliciano, Josephine Louella; McLoone, Dylan; Xu, Yingxin; Quek, Ruben G W; Kuznik, Andreas; Pouliot, Jean-Francois; Gullo, Giuseppe; Rietschel, Petra; Guyot, Patricia; Konidaris, Gerasimos; Chan, Keith; Keeping, Sam; Wilson, Florence R; Freemantle, Nick.
Affiliation
  • Feliciano JL; Johns Hopkins University, Baltimore, MD, United States.
  • McLoone D; PRECISIONheor, Boston, MA, United States.
  • Xu Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.
  • Quek RGW; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.
  • Kuznik A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.
  • Pouliot JF; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.
  • Gullo G; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.
  • Rietschel P; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.
  • Guyot P; Sanofi, Chilly-Mazarin, France.
  • Konidaris G; Sanofi, Reading, United Kingdom.
  • Chan K; PRECISIONheor, Vancouver, BC, Canada.
  • Keeping S; PRECISIONheor, Vancouver, BC, Canada.
  • Wilson FR; PRECISIONheor, Vancouver, BC, Canada.
  • Freemantle N; Institute of Clinical Trials and Methodology, University College London, London, United Kingdom.
Front Oncol ; 12: 1081729, 2022.
Article in En | MEDLINE | ID: mdl-37082098
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Guideline / Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: United States Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Guideline / Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: United States Country of publication: Switzerland